TI nulling and contrast conditions with a 0.15 mmol/kg dosage of MultiHance as compared to the standard 0.2 mmol/kg gadolinium dosage in patients with myocardial infarcts

Liknande verk

• 1023 Correlation of chronic left ventricular infarct size assessed with 0.2 mmol/kg of gadopentetate dimeglumine (Gd-DTPA) and 0.1 mmol/kg gadobenate dimeglumine (Gd-BOPTA)
  av: Lane Kimberly, et al.
  Publicerad: (2008-10-01)
• Assessment of the economic evaluation of the contrast agent MultiHance
  av: A. S. Kolbin, et al.
  Publicerad: (2018-06-01)
• No glucotoxicity after 53 hours of 6.0 mmol/l hyperglycaemia in normal man.
  av: Flax, H, et al.
  Publicerad: (1991)
• 403 Do heart rate, ejection fraction, stroke volume and cardiac output play a key role in optimal myocardial nulling?
  av: Biederman Robert WW, et al.
  Publicerad: (2008-10-01)
• Validating Physiological and Biomechanical Parameters During Intermittent Swimming at Speed Corresponding to Lactate Concentration of 4 mmol/L
  av: Gavriil G. Arsoniadis, et al.
  Publicerad: (2019-08-01)